Skip to Content

TV 2134 (Minocycline Hydrochloride Extended-Release 65 mg)

Pill with imprint TV 2134 is Purple, Capsule-shape and has been identified as Minocycline Hydrochloride Extended-Release 65 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; periodontitis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 65 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 2134

Minocycline hydrochloride extended-release 65 mg TV 2134

Minocycline Hydrochloride Extended-Release

TV 2134
65 mg
16.00 mm
Prescription only
Drug Class
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
Inactive Ingredients
carnauba wax, silicon dioxide, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 3350, polyethylene glycol 4000, titanium dioxide, triacetin, D&C Red No. 27, aluminum oxide, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.